Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids

European Respiratory Journal

Volumn 32, Issue 4, 2008, Pages 1047-1052

  Holme, J ^a   Tomlinson, J W ^a   Stockley, R A ^a,c   Stewart, P M ^a   Barlow, N ^b   Sullivan, A L ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Adrenal insufficiency; Bronchiectasism; Glucocorticoids; Inhaled corticosteroid; Short synacthen test

Indexed keywords

CORTICOSTEROID; FLUTICASONE; HYDROCORTISONE; PREDNISOLONE; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ADULT; AGED; ARTHRALGIA; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FATIGUE; FEMALE; FREQUENCY ANALYSIS; HEALTH STATUS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTENSION; LETHARGY; LUNG FUNCTION; MALAISE; MALE; NAUSEA; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; VOMITING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENAL GLANDS; ADRENAL INSUFFICIENCY; ADULT; AGED; AGED, 80 AND OVER; BRONCHIECTASIS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; STEROIDS; TREATMENT OUTCOME;

EID: 58849155091     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00016908     Document Type: Article

References (28)

1. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001; 17: 1112-1119.
2. Donnelly R, Williams KM, Baker AB, Badcock CA, Day RO, Seale JP. Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study. Am J Respir Crit Care Med 1997; 156: 1746-1751.
3. British guideline on the management of asthma. Thorax 2003; 58: Suppl. 1, i1-i94.
4. Brown PH, Blundell G, Greening AP, Crompton GK. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids. Respir Med 1991; 85: 511-516.
5. Chervinsky P, van As A, Bronsky EA, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. J Allergy Clin Immunol 1994; 94: 676-683.
6. Dahl R, Lundback B, Malo JL, et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group. Chest 1993; 104: 1352-1358.
7. Wilson AM, McFarlane LC, Lipworth BJ. Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers. J Clin Endocrinol Metab 1998; 83: 922-925.
8. Szefler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary- adrenal axis function in patients with moderate-to-severe persistent asthma. Chest 2005; 128: 1104-1114.
9. Rouanet I, Peyriere H, Mauboussin JM, Vincent D. Cushing's syndrome in a patient treated by ritonavir/ lopinavir and inhaled fluticasone. HIV Med 2003; 4: 149-150.
10. Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol 2006; 13: 930-936.
11. Quanjer PH, Tammeling GJ, Cotes JE, et al. Symbols, abbreviations and units. Working Party Standardisation of Lung Function Tests, European Community for Steel and Coal. Eur Respir J 1993; 6: Suppl. 16, 85-100.
12. Stewart PM, Clark PM, Sheppard MC. Comparison of the short ACTH stimulation test with the insulin tolerance/ glucagon test. Clin Endocrinol (Oxf) 1998; 48: 124-126.
13. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
14. Eichenhorn MS, Wise RA, Madhok TC, et al. Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II. Chest 2003; 124: 57-62.
15. Niitsuma T, Okita M, Sakurai K, et al. Adrenal function as assessed by low-dose adrenocorticotropin hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled fluticasone propionate. J Asthma 2003; 40: 515-522.
16. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348: 727-734.
17. Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991; 337: 582-583.
18. Gannon TA, Britt RC, Weireter LJ, Cole FJ, Collins JN, Britt LD. Adrenal insufficiency in the critically ill trauma population. Am Surg 2006; 72: 373-376.
19. Bernard F, Matta BF. Adrenal insufficiency after brain injury. Intensive Care Med 2006; 32: 793.
20. Kolbe J, Wells A, Ram FS. Inhaled steroids for bronchiectasis. Cochrane Database Syst Rev 2000: 2; CD000996.
21. Jain NK, Gupta KN, Sharma TN, Garg VK, Agnihotri SP. Airway obstruction in bronchiectasis and its reversibility - a study of 38 patients. Indian J Chest Dis Allied Sci 1992; 34: 7-10.
22. Ip M, Lam WK, So SY, Liong E, Chan CY, Tse KM. Analysis of factors associated with bronchial hyperreactivity to methacholine in bronchiectasis. Lung 1991; 169: 43-51.
23. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992; 35: 1281-1288.
24. Gaillard RC, Turnill D, Sappino P, Muller AF. Tumour necrosis factor-α inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 1990; 127: 101-106.
25. Jaattela M, Ilvesmaki V, Voutilainen R, Stenman UH, Saksela E. Tumour necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human foetal adrenal cells. Endocrinology 1991; 128: 623-629.
26. Calogero AE, Sternberg EM, Bagdy G, et al. Neurotransmitter- induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 1992; 55: 600-608.
27. Agwu JC, Spoudeas H, Hindmarsh PC, Pringle PJ, Brook CG. Tests of adrenal insufficiency. Arch Dis Child 1999; 80: 330-333.
28. Kaliner MA. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: a comparison of ciclesonide and fluticasone propionate. Clin Ther 2006; 28: 319-331.